ATE149504T1 - Sulfatierte glykosaminoglycanoidderivate - Google Patents

Sulfatierte glykosaminoglycanoidderivate

Info

Publication number
ATE149504T1
ATE149504T1 AT92202507T AT92202507T ATE149504T1 AT E149504 T1 ATE149504 T1 AT E149504T1 AT 92202507 T AT92202507 T AT 92202507T AT 92202507 T AT92202507 T AT 92202507T AT E149504 T1 ATE149504 T1 AT E149504T1
Authority
AT
Austria
Prior art keywords
sulfate
groups
oalk
replaced
functional
Prior art date
Application number
AT92202507T
Other languages
English (en)
Inventor
Maurice Petitou
Boeckel Constant Adriaan A Van
Original Assignee
Akzo Nobel Nv
Sanofi Elf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv, Sanofi Elf filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE149504T1 publication Critical patent/ATE149504T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/08—Polyoxyalkylene derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT92202507T 1991-08-23 1992-08-17 Sulfatierte glykosaminoglycanoidderivate ATE149504T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91402299 1991-08-23

Publications (1)

Publication Number Publication Date
ATE149504T1 true ATE149504T1 (de) 1997-03-15

Family

ID=8208605

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92202507T ATE149504T1 (de) 1991-08-23 1992-08-17 Sulfatierte glykosaminoglycanoidderivate

Country Status (19)

Country Link
EP (1) EP0529715B1 (de)
JP (1) JP3048198B2 (de)
KR (1) KR100274115B1 (de)
AT (1) ATE149504T1 (de)
AU (1) AU656610B2 (de)
BR (1) BR1100632A (de)
CA (1) CA2076063C (de)
DE (1) DE69217774T2 (de)
DK (1) DK0529715T3 (de)
ES (1) ES2101026T3 (de)
FI (1) FI111726B (de)
GR (1) GR3023580T3 (de)
HK (1) HK1002032A1 (de)
HU (2) HUT62594A (de)
IL (1) IL102758A (de)
NO (1) NO179452C (de)
NZ (1) NZ244057A (de)
TW (1) TW213470B (de)
ZA (1) ZA926029B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2157388C (en) * 1993-03-01 1998-12-15 Daniel P. Witt Analogs for specific oligosaccharide-protein interactions and uses thereof
FR2704226B1 (fr) * 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
IL120722A (en) * 1996-05-08 1999-07-14 Akzo Nobel Nv Polysulfated tetrasaccharide derivatives and pharmaceutical compositions containing them
FR2751334B1 (fr) 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
IL126893A (en) 1997-11-19 2003-05-29 Akzo Nobel Nv Sulfated pentasaccharide derivatives and pharmaceutical compositions containing them
FR2773801B1 (fr) * 1998-01-19 2000-05-12 Sanofi Sa Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant
US6083933A (en) * 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
CA2435637A1 (en) 2001-01-23 2002-08-01 Massachusetts Institute Of Technology Solid- and solution -phase synthesis of heparin and other glycosaminoglycans
EP1569912B1 (de) 2002-12-03 2015-04-29 Pharmacyclics, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidinderivate als faktor vii-a hemmer
US20040161476A1 (en) 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
CA2576131C (en) 2004-08-05 2012-04-24 Ivax Drug Research Institute Ltd. Polysulfated glycosides and salts thereof
FR2874924B1 (fr) 2004-09-09 2006-12-01 Sanofi Aventis Sa Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
TWI403334B (zh) 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
TWI376234B (en) 2005-02-01 2012-11-11 Msd Oss Bv Conjugates of a polypeptide and an oligosaccharide
EP2279249A4 (de) 2008-05-30 2014-03-05 Momenta Pharmaceuticals Inc Saccharidstrukturen und verfahren zu ihrer herstellung und verwendung
FR2938541B1 (fr) * 2008-11-20 2011-08-26 Sanofi Aventis Pentasaccharide cristallise,son procede d'obtention et son utilisation pour la preparation d'idraparinux
FR2949115B1 (fr) 2009-08-14 2012-11-02 Sanofi Aventis OLIGOSACCHARIDES N-SULFATES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2949114B1 (fr) 2009-08-14 2011-08-26 Sanofi Aventis OCTASACCHARIDES N-ACYLES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
JP2013537181A (ja) 2010-09-10 2013-09-30 サノフイ 抗血栓活性及び改善された代謝安定性を有するビオチン化多糖類
FR2970969B1 (fr) 2011-01-27 2013-10-18 Sanofi Aventis Oligosaccharides 3-o-alkyles activateurs des recepteurs des fgfs, leur preparation et leur application en therapeutique
EP2578594A1 (de) 2011-10-04 2013-04-10 Sanofi Verfahren zur Herstellung von L-Iduronsäure mittels einer Decarboxylierung/intramolekulare Zyklisierungs-Tandemreaktion
AU2022365434A1 (en) * 2021-10-14 2024-05-02 Owlstone Medical Limited Method for the synthesis of evoc probes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3017407A (en) * 1958-08-18 1962-01-16 Riker Laboratories Inc Process for producing polysulfuric acid esters of polysaccharides
GB1110939A (en) * 1965-10-06 1968-04-24 Meito Sangyo Kk Sulphuric acid esters of disaccharides and hexitols,and their use as antipeptic ulcer agents
HU172937B (hu) * 1975-12-18 1979-01-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh khondroitin-sernoj kisloty s mestno anestezirujuhhim ehffektom
US4818816A (en) * 1981-04-28 1989-04-04 Choay, S.A. Process for the organic synthesis of oligosaccharides and derivatives thereof
FR2543145B1 (fr) * 1983-03-24 1986-10-17 Sanofi Sa Nouveaux sulfates de xylanes, leur procede de preparation et leur activite anti-thrombotique et hypolipemiante
AU607690B2 (en) * 1985-12-24 1991-03-14 Marion Laboratories, Inc. Use of synthetic sulfated saccharides to enhance wound healing
EP0300099A1 (de) * 1987-07-20 1989-01-25 Akzo N.V. Pentasaccharide
DK0454220T3 (da) * 1990-04-23 1993-11-22 Sanofi Elf Carbohydratderivater omfattende en trisaccharidenhed
EP2301618B1 (de) * 2009-09-23 2011-12-07 Covidien AG Dilatationsvorrichtung zum Dilatieren einer Öffnung

Also Published As

Publication number Publication date
TW213470B (de) 1993-09-21
BR1100632A (pt) 2000-06-13
ZA926029B (en) 1993-03-10
NZ244057A (en) 1995-05-26
NO179452C (no) 1996-10-09
NO923297L (no) 1993-02-24
JP3048198B2 (ja) 2000-06-05
FI923726L (fi) 1993-02-24
EP0529715B1 (de) 1997-03-05
CA2076063C (en) 2003-12-30
NO923297D0 (no) 1992-08-21
AU2121892A (en) 1993-02-25
AU656610B2 (en) 1995-02-09
CA2076063A1 (en) 1993-02-24
KR100274115B1 (ko) 2000-12-15
EP0529715A1 (de) 1993-03-03
DE69217774D1 (de) 1997-04-10
GR3023580T3 (en) 1997-08-29
ES2101026T3 (es) 1997-07-01
DK0529715T3 (da) 1997-09-08
DE69217774T2 (de) 1997-06-26
HK1002032A1 (en) 1998-07-24
KR930004324A (ko) 1993-03-22
HU211738A9 (en) 1995-12-28
JPH05194602A (ja) 1993-08-03
FI923726A0 (fi) 1992-08-19
FI111726B (fi) 2003-09-15
NO179452B (no) 1996-07-01
HUT62594A (en) 1993-05-28
IL102758A0 (en) 1993-01-31
IL102758A (en) 1997-03-18

Similar Documents

Publication Publication Date Title
DE69217774D1 (de) Sulfatierte Glykosaminoglycanoidderivate
ES2062987T3 (es) Compuestos de actividad farmaceutica.
NL980026I1 (nl) Nieuwe camptothecinederivaten en werkwijze voor debereiding hiervan.
UA26427A (uk) Похідhі ксаhтиhу у вигляді суміші ізомерів або іhдивідуальhих ізомерів, що мають властивість аhтагоhіста адеhозиhу
GR3021169T3 (en) Pharmacological active hydrazin derivatives and process for their preparation
DK0513675T3 (da) Hidtil ukendt peptidforbindelse samt fremgangsmåde til fremstilling deraf
ATE110382T1 (de) Oxetanocin.
MD960212A (en) Acylfulvene analogs as antitumor remedy
ES2056073T3 (es) Aril-aralquil-eteres, procedimientos para su preparacion y composicion farmaceutica que los comprende.
GB2090833B (en) Trisubstituted pyrimido (5,4-d) pyrimidines
ES8706148A1 (es) Un procedimiento para preparar nuevos derivados de carbapenem.
ES457783A1 (es) Procedimiento para la preparacion de nuevos derivados de xantina.
ES8706690A1 (es) Un procedimiento para la preparacion de nuevos derivados de penem.
ES516362A0 (es) "procedimiento para la preparacion de un oligomero de un disocianato alifatico".
IE811349L (en) Adenine nucleosides
IL76652A0 (en) Thiadiazole derivatives,their preparation and pharmaceutical compositions containing them
MX9200665A (es) Derivados de ureas y tioureas disubstituidas, procedimiento para su preparacion y composiciones farmaceuticas que los contiene.
FR2533561B1 (fr) Procede de preparation des carbamates vinyliques et nouveaux carbamates vinyliques
KR890009916A (ko) 랩단 유도체, 이의 제조 방법 및 이의 약제로서의 용도
KR910011885A (ko) 면역 활성 및 항종양 활성이 있는 리피드 a동족체
ES8401093A1 (es) "proceso para la produccion de 5,3',4',6"-tetradesoxikanamicina b".

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification